<Disease><Name>METACHROMATIC LEUKODISTROPHY (MLD)</Name><Synonym>METACHROMATIC LEUKODYSTROPHY, JUVENILE</Synonym><OMIM><Number>250100</Number><URL>http://omim.org/entry/250100</URL></OMIM><Orphanet><Number>512</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=512</URL></Orphanet><Protein><Number>arylsulfatse A</Number><URL>http://www.uniprot.org/uniprot/P15289</URL></Protein><ExPASy><Number /><URL /></ExPASy><Gene>22q13.33</Gene><ICD>E75.2</ICD><Summary>rare (1:40000);autosomal recessive ;mutation in the arylsulfatase A gene;3 types: ;-late infantile;- juvenile;- adult form ;&gt;40 different mutations</Summary><Symptoms><symtomp><id>1942</id><symptom>ataxia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2323</id><symptom>behavior, abnormal or bizarre, confusion / behaviour, abnormal or bizarre</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2401</id><symptom>conjunctival biopsy, abnormal</symptom><category>LABORATORY FINDINGS | LABORATORY FINDINGS</category></symtomp><symtomp><id>1948</id><symptom>defect of walking, running, rising or climbing</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2164</id><symptom>dysarthria</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>1946</id><symptom>dystonia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2160</id><symptom>EEG abnormalities [-]</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>2374</id><symptom>Fanconi syndrome</symptom><category>GENERAL TOPICS | GENITOURINARY TRACT</category></symtomp><symtomp><id>3848</id><symptom>gait disturbance</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2346</id><symptom>gallbladder abnormalities</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2261</id><symptom>hyperreflexia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2214</id><symptom>hyporeflexia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1897</id><symptom>hypotonia</symptom><category>MUSCLES | NERVOUS SYSTEM</category></symtomp><symtomp><id>3843</id><symptom>leukodystrophy</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2424</id><symptom>mental retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1941</id><symptom>motor retardation / motor developmental delay</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2426</id><symptom>MRI, brain, white matter abnormalities [-]</symptom><category>LABORATORY FINDINGS | NERVOUS SYSTEM</category></symtomp><symtomp><id>1787</id><symptom>muscle weakness</symptom><category>MUSCLES</category></symtomp><symtomp><id>4112</id><symptom>Nerve conductive velocity, slow</symptom><category /></symtomp><symtomp><id>1723</id><symptom>nystagmus</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>1915</id><symptom>onset, adulthood / adoulthood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1739</id><symptom>optic atrophy</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>1939</id><symptom>peripheral neuropathy</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1919</id><symptom>progressive neurologic defect</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1943</id><symptom>seizures</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>1974</id><symptom>spastic diplegia/quadriplegia/tetraplegia</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp></Symptoms><Metabolites><metabolite><id>896</id><name>Arylsulfatase A</name><specimen>fibroblasts</specimen><value /><min>    </min><max>100.00</max><unit>% activity</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>766</id><name>Protein, total</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>10.00</min><max>30.00</max><unit>mg/dl</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1096</id><name>Protein</name><specimen>urine</specimen><value>increased</value><min>50.00</min><max>80.00</max><unit>mg/24 hr</unit><age>no data</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>4767</id><title>Four novel ARSA gene mutations with pathogenic impacts on metachromatic leukodystrophy: a bioinformatics approach to predict pathogenic mutations</title><author>Dehghan Manshadi M,</author><journal>Ther Clin Risk Manag</journal><year>2017</year><book /><volume>13</volume><number>0</number><pages>725-731</pages><co_aut>et al.</co_aut></literature><literature><id>4768</id><title>Gene therapy for metachromatic leukodystrophy</title><author>Rosenberg JB,</author><journal>J Neurosci Res</journal><year>2016</year><book /><volume>94</volume><number>11</number><pages>1169-1179</pages><co_aut>et al.</co_aut></literature><literature><id>4769</id><title>Mutation Update of ARSA and PSAP Genes Causing Metachromatic Leukodystrophy</title><author>Cesani M,</author><journal>Hum Mutat</journal><year>2016</year><book /><volume>37</volume><number>1</number><pages>16-27</pages><co_aut>et al.</co_aut></literature><literature><id>4770</id><title>Metachromatic leukodystrophy: Disease spectrum and approaches for treatment</title><author>van Rappard DF,</author><journal>Best Pract Res Clin Endocrinol Metab</journal><year>2015</year><book /><volume>29</volume><number>2</number><pages>261-273</pages><co_aut>Boelens JJ, Wolf NI</co_aut></literature><literature><id>4771</id><title>Developing therapeutic approaches for metachromatic leukodystrophy</title><author>Patil SA,</author><journal>Drug Des Devel Ther</journal><year>2013</year><book /><volume>7</volume><number>0</number><pages>729-745</pages><co_aut>Maegawa GH</co_aut></literature><literature><id>2716</id><title>Enzyme, cell and gene-based therapies for metachromatic leukodystrophy</title><author>Sevin C</author><journal>J Inher Met Dis</journal><year>2007</year><book /><volume>30</volume><number>0</number><pages>175-183</pages><co_aut>Aubourg P, Cartier N</co_aut></literature><literature><id>2289</id><title>Expression and purification of a human, soluble Arylsulfatase A for Metachromatic Leukodystrophy enzyme replacement therapy</title><author>Martino S</author><journal>J Biotechnol</journal><year>2005</year><book /><volume>117</volume><number>3</number><pages>243-251</pages><co_aut>et al.</co_aut></literature><literature><id>2290</id><title>Gene therapy of metachromatic leukodystrophy</title><author>Matzner U</author><journal>Expert Opin Biol Ther</journal><year>2005</year><book /><volume>5</volume><number>1</number><pages>55-65</pages><co_aut>Gieselmann V</co_aut></literature><literature><id>2291</id><title>Metachromatic leukodystrophy: recent research developments</title><author>Gieselmann V</author><journal>J Child Neurol</journal><year>2003</year><book /><volume>18</volume><number>9</number><pages>591-594</pages><co_aut /></literature><literature><id>954</id><title>Metachromatic leukodystrophy: molecular genetics and an animal model</title><author>Gieselmann V</author><journal>J Inherit Metab Dis</journal><year>1998</year><book /><volume>21</volume><number>0</number><pages>564-574</pages><co_aut>et al.</co_aut></literature><literature><id>766</id><title>Recurrent seizures in metachromatic leukodystrophy</title><author>Balslev T</author><journal>Pediatr Neurol</journal><year>1997</year><book /><volume>17</volume><number>0</number><pages>150-154</pages><co_aut>et al.</co_aut></literature><literature><id>585</id><title>A D255H substitution in the arylsulfatase A gene of two unrelated Belgian patients with late-infantile metachromatic leukodystro</title><author>Lissens W</author><journal>J Inherit Metab Dis</journal><year>1996</year><book /><volume>19</volume><number>0</number><pages>782-786</pages><co_aut>et al.</co_aut></literature><literature><id>636</id><title>Neuropathy of metachromatic leukodystrophy: improvement with immunomodulation</title><author>Nevo Y</author><journal>Pediatr Neurol</journal><year>1996</year><book /><volume>15</volume><number>0</number><pages>237-239</pages><co_aut>et al.</co_aut></literature><literature><id>57</id><title>The future for treatment by bone marrow transplantation for adrenoleukodystrophy, metachromatic leukodystrophy, globoid cell leu</title><author>Krivit W</author><journal>J Inherit Metab Dis</journal><year>1995</year><book /><volume>18</volume><number>0</number><pages>398-412</pages><co_aut>Lockman LA, Watkins PA, Hirsch J, Shapiro EG</co_aut></literature><literature><id>58</id><title>Metachromatic leukodystrophy and multiple sulfatase deficiency: sulfatide lipidosis</title><author>Kolodny EH</author><journal>The metabolic and molecular bases of inherited disease, 7/e; Editors: C.R.Scriver, A.L.Beaudet, W.S.Sly, D.Valle; McGraw-Hill Inc.</journal><year>1995</year><book /><volume>2</volume><number>0</number><pages>2693-2739</pages><co_aut>Fluharty AL</co_aut></literature><literature><id>470</id><title>Molecular basis of late infantile metachromatic leukodystrophy in the Habbanite Jews</title><author>Zlotogora J</author><journal>Hum Mutat</journal><year>1995</year><book /><volume>5</volume><number>2</number><pages>137-143</pages><co_aut>et al.</co_aut></literature></Literatures></Disease>